Serum MMP-8: A Novel Indicator of Left Ventricular Remodeling and Cardiac Outcome in Patients after Acute Myocardial Infarction

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Fertin, Marie ^a,b,c,d   Lemesle, Gilles ^a,b,c,d   Turkieh, Annie ^b,c,d   Beseme, Olivia ^b,c,d   Chwastyniak, Maggy ^c,d   Amouyel, Philippe ^a,b,c,d   Bauters, Christophe ^a,b,c,d   Pinet, Florence ^a,b,c,d  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c INSERM   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; NEUTROPHIL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD SAMPLING; ECHOCARDIOGRAPHY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROSPECTIVE STUDY;

ACUTE DISEASE; BIOLOGICAL MARKERS; ELECTROCARDIOGRAPHY; ENDPOINT DETERMINATION; FEMALE; HEART; HUMANS; MALE; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; TISSUE INHIBITOR OF METALLOPROTEINASES; VENTRICULAR REMODELING;

EID: 84881491983     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071280     Document Type: Article

References (27)

1. Pfeffer MA, Braunwald E, (1990) Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161-1172.
2. St John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moye LA, et al. (1994) Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 89: 68-75.
3. Savoye C, Equine O, Tricot O, Nugue O, Segrestin B, et al. (2006) Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the remodelage ventriculaire [REVE] study group). Am J Cardiol 98: 1144-1149.
4. Fertin M, Hennache B, Hamon M, Ennezat PV, Biausque F, et al. (2010) Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study). Am J Cardiol 106: 1410-1416.
5. St John Sutton M, Pfeffer MA, Moye L, Plappert T, Rouleau JL, et al. (1997) Cardiovascular death and left ventricular remodeling two years after myocardial infarction: Baseline predictors and impact of long-term use of captopril: Information from the survival and ventricular enlargement (SAVE) trial. Circulation 96: 3294-3299.
6. Fertin M, Dubois E, Belliard A, Amouyel P, Pinet F, et al. (2012) Usefulness of circulating biomarkers for the prediction of left ventricular remodeling after myocardial infarction. Am J Cardiol 110: 277-283.
7. Spinale FG, (2007) Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function. Physiol Rev 87: 1285-1342.
8. Etoh T, Joffs C, Deschamps AM, Davis J, Dowdy K, et al. (2001) Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs. Am J Physiol Heart Circ Physiol 281: H987-H994.
9. Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukhova GH, et al. (1999) Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 99: 3063-3070.
10. Creemers EE, Davis JN, Parkhurst AM, Leenders P, Dowdy KB, et al. (2003) Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 284: H364-H371.
11. Bolognese L, Neskovic AN, Parodi G, Cerisano G, Buonamici P, et al. (2002) Left ventricular remodeling after primary coronary angioplasty: Patterns of left ventricular dilation and long-term prognostic implications. Circulation 106: 2351-2357.
12. Garcia-Alvarez A, Sitges M, Delgado V, Ortiz J, Vidal B, et al. (2009) Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance. Am J Cardiol 104: 878-882.
13. Lalu MM, Pasini E, Schulze CJ, Ferrari-Vivaldi M, Ferrari-Vivaldi G, et al. (2005) Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart. Eur Heart J 26: 27-35.
14. Webb CS, Bonnema DD, Ahmed SH, Leonardi AH, McClure CD, et al. (2006) Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: Relation to left ventricular remodeling. Circulation 114: 1020-1027.
15. Samnegard A, Silveira A, Tornvall P, Hamsten A, Ericsson CG, et al. (2006) Lower serum concentration of matrix metalloproteinase-3 in the acute stage of myocardial infarction. J Intern Med 259: 530-536.
16. Gerlach RF, Meschiari CA, Marcaccini AM, Palei AC, Sandrim VC, et al. (2009) Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions. Clin Chem Lab Med 47: 888-891.
17. Nilsson L, Hallen J, Atar D, Jonasson L, Swahn E, (2012) Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction. Heart 98: 31-36.
18. van den Borne SW, Cleutjens JP, Hanemaaijer R, Creemers EE, Smits JF, et al. (2009) Increased matrix metalloproteinase-8 and-9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc Pathol 18: 37-43.
19. Squire IB, Evans J, Ng LL, Loftus IM, Thomspson MM, (2004) Plasma MMP-2 and MMP-9 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction. J Card Fail 10: 328-333.
20. Kelly D, Cockerill G, Ng LL, Thompson M, Khan S, et al. (2007) Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: A prospective cohort study. Eur Heart J 28: 711-718.
21. Kelly D, Khan SQ, Thompson M, Cockerill G, Ng LL, et al. (2008) Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: Novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction. Eur Heart J 29: 2116-2124.
22. Miyazaki S, Kasai T, Miyauchi K, Miyazaki T, Akimoto Y, et al. (2010) Changes of matrix metalloproteinase-9 level is associated with left ventricular remodeling following acute myocardial infarction among patients treated with trandolapril, valsartan or both. Circ J 74: 1158-1164.
23. Kelly D, Khan S, Cockerill G, Ng LL, Thompson M, et al. (2008) Circulating stromelysin-1 (MMP-3): A novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction. Eur J Heart Fail 10: 133-139.
24. Weir RA, Balmain S, Steedman T, Ng LL, Squire IB, et al. (2010) Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction. J Thromb Thrombolysis 29: 421-428.
25. Weir RA, Clements S, Steedman T, Dargie HJ, McMurray JJ, et al. (2011) Plasma TIMP-4 predicts left ventricular remodeling after acute myocardial infarction. J Card Fail 17: 465-471.
26. Tuomainen AM, Nyyssonen K, Laukkanen JA, Tervahartiala T, Tuomainen TP, et al. (2007) Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler Thromb Vasc Biol 27: 2722-2728.
27. Peeters W, Moll FL, Vink A, van der Spek PJ, de Kleijn DP, et al. (2011) Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome. Eur Heart J 32: 2314-2325.